FDA Declines Specific Guidance on Foreign Drug Imports by Health Programs

The U.S. Food and Drug Administration has declined to issue specific guidance regarding the import of prescription drugs from overseas by health programs. This decision follows a CNBC investigation that highlighted the proliferation of such programs, which regulators consider a violation of import laws.